相似文献
1
Efficacy of herpes simplex virus type 1 immunization in protecting against acute and latent infection by herpes simplex virus type 2 in mice.
Infect Immun. 1977 May;16(2):717-9. doi: 10.1128/iai.16.2.717-719.1977.
2
Acute and latent herpes simplex virus neurological disease in mice immunized with purified virus-specific glycoproteins gB or gD.
J Med Virol. 1985 Sep;17(1):9-18. doi: 10.1002/jmv.1890170103.
3
Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination.
J Virol. 1988 May;62(5):1530-4. doi: 10.1128/JVI.62.5.1530-1534.1988.
4
Effect of immunization on acute and latent infections of vaginouterine tissue with herpes simplex virus types 1 and 2.
J Infect Dis. 1977 May;135(5):744-52. doi: 10.1093/infdis/135.5.744.
5
Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection.
J Exp Med. 1985 Oct 1;162(4):1304-18. doi: 10.1084/jem.162.4.1304.
6
Effect of immunization on the development of latent ganglionic infection in mice challenged intravaginally with herpes simplex virus types 1 and 2.
Am J Obstet Gynecol. 1978 Aug 1;131(7):788-91. doi: 10.1016/0002-9378(78)90248-x.
7
Effect of immunization on herpes simplex virus type 1 latent infection in the trigeminal ganglion.
Curr Eye Res. 2003 Mar-Apr;26(3-4):185-94. doi: 10.1076/ceyr.26.3.185.14891.
8
Efficacy of oral administration of live herpes simplex virus type 1 as a vaccine.
J Virol. 1992 Apr;66(4):2428-34. doi: 10.1128/JVI.66.4.2428-2434.1992.
9
Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease.
Infect Immun. 1981 Oct;34(1):192-9. doi: 10.1128/iai.34.1.192-199.1981.
10
Immunization with replication-defective mutants of herpes simplex virus type 1: sites of immune intervention in pathogenesis of challenge virus infection.
J Virol. 1994 Feb;68(2):689-96. doi: 10.1128/JVI.68.2.689-696.1994.
引用本文的文献
1
A Broad Influenza Vaccine Based on a Heat-Activated, Tissue-Restricted Replication-Competent Herpesvirus.
Vaccines (Basel). 2024 Jun 23;12(7):703. doi: 10.3390/vaccines12070703.
2
Immunization by Replication-Competent Controlled Herpesvirus Vectors.
J Virol. 2018 Jul 31;92(16). doi: 10.1128/JVI.00616-18. Print 2018 Aug 15.
3
Immunogenicity of herpes simplex virus glycoproteins gC and gB and their role in protective immunity.
J Virol. 1984 Jun;50(3):805-12. doi: 10.1128/JVI.50.3.805-812.1984.
4
Colonization of murine ganglia by a superinfecting strain of herpes simplex virus.
Infect Immun. 1983 Aug;41(2):702-8. doi: 10.1128/iai.41.2.702-708.1983.
5
Immunogenicity and protective efficacy in a rhesus monkey model of vaccine Ac NFUi(S-) MRC against primary type 2 herpes simplex virus infection.
Br J Exp Pathol. 1982 Aug;63(4):378-87.
6
Preparation and immunogenicity of vaccine Ac NFU1 (S-) MRC towards the prevention of herpes genitalis.
Br J Vener Dis. 1982 Dec;58(6):381-6. doi: 10.1136/sti.58.6.381.
7
Initial herpes simplex virus type 1 infection prevents ganglionic superinfection by other strains.
Infect Immun. 1982 Mar;35(3):1125-32. doi: 10.1128/iai.35.3.1125-1132.1982.
8
Experimental ulcerative herpetic keratitis. IV. Preliminary observations on the efficacy of a herpes simplex subunit vaccine.
Br J Ophthalmol. 1981 Oct;65(10):679-82. doi: 10.1136/bjo.65.10.679.
9
The influence of different modes of immunization on the experimental genital herpes simplex virus infection of mice.
Med Microbiol Immunol. 1981;169(4):269-79. doi: 10.1007/BF02125526.
10
Immune responses in mice against herpes simplex virus: mechanisms of protection against facial and ganglionic infections.
Infect Immun. 1981 Jan;31(1):267-75. doi: 10.1128/iai.31.1.267-275.1981.
本文引用的文献
1
2
THE PATHOGENESIS OF HERPES VIRUS ENCEPHALITIS. II. A CELLULAR BASIS FOR THE DEVELOPMENT OF RESISTANCE WITH AGE.
J Exp Med. 1964 Sep 1;120(3):359-74. doi: 10.1084/jem.120.3.359.
3
THE PATHOGENESIS OF HERPES VIRUS ENCEPHALITIS. I. VIRUS PATHWAYS TO THE NERVOUS SYSTEM OF SUCKLING MICE DEMONSTRATED BY FLUORESCENT ANTIBODY STAINING.
J Exp Med. 1964 Feb 1;119(2):343-56. doi: 10.1084/jem.119.2.343.
4
Depression of acquired resistance against herpes simplex virus infection in neonatally thymectomized mice.
Arch Gesamte Virusforsch. 1967;21(3):459-62. doi: 10.1007/BF01241745.
5
Herpes virus latency in spinal ganglia of mice without illness.
Proc Soc Exp Biol Med. 1974 Sep;146(4):1093-6. doi: 10.3181/00379727-146-38251.
6
Infection with herpes-simplex viruses 1 and 2. 3.
N Engl J Med. 1973 Oct 11;289(15):781-9. doi: 10.1056/NEJM197310112891505.
7
Infection with herpes-simplex viruses 1 and 2. II.
N Engl J Med. 1973 Oct 4;289(14):719-25. doi: 10.1056/NEJM197310042891404.
8
A review of the identification and titration of antibodies to herpes simplex viruses type 1 and type 2 in human sera.
Cancer Res. 1973 Jun;33(6):1469-76.
9
Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence for intra-axonal transport of infection.
Infect Immun. 1973 Feb;7(2):272-88. doi: 10.1128/iai.7.2.272-288.1973.
10
Type 1 and type 2 herpes simplex viruses: serological and biological differences.
J Virol. 1970 Jan;5(1):51-9. doi: 10.1128/JVI.5.1.51-59.1970.
Zotero 插件